230 related articles for article (PubMed ID: 15684406)
1. Proteomic profiling of pancreatic cancer for biomarker discovery.
Chen R; Pan S; Brentnall TA; Aebersold R
Mol Cell Proteomics; 2005 Apr; 4(4):523-33. PubMed ID: 15684406
[TBL] [Abstract][Full Text] [Related]
2. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
Pan S; Chen R; Crispin DA; May D; Stevens T; McIntosh MW; Bronner MP; Ziogas A; Anton-Culver H; Brentnall TA
J Proteome Res; 2011 May; 10(5):2359-76. PubMed ID: 21443201
[TBL] [Abstract][Full Text] [Related]
3. Strategies for discovering novel pancreatic cancer biomarkers.
Chan A; Diamandis EP; Blasutig IM
J Proteomics; 2013 Apr; 81():126-34. PubMed ID: 23026552
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics Tools and Workflow to Select Blood Biomarkers for Early Cancer Diagnosis: An Application to Pancreatic Cancer.
Vandenbrouck Y; Christiany D; Combes F; Loux V; Brun V
Proteomics; 2019 Nov; 19(21-22):e1800489. PubMed ID: 31538697
[TBL] [Abstract][Full Text] [Related]
5. Translational Research and Plasma Proteomic in Cancer.
Santini AC; Giovane G; Auletta A; Di Carlo A; Fiorelli A; Cito L; Astarita C; Giordano A; Alfano R; Feola A; Di Domenico M
J Cell Biochem; 2016 Apr; 117(4):828-35. PubMed ID: 26479787
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
7. Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.
Coleman O; Henry M; McVey G; Clynes M; Moriarty M; Meleady P
Expert Rev Proteomics; 2016; 13(4):383-94. PubMed ID: 26985644
[TBL] [Abstract][Full Text] [Related]
8. Applying proteomic-based biomarker tools for the accurate diagnosis of pancreatic cancer.
Kojima K; Asmellash S; Klug CA; Grizzle WE; Mobley JA; Christein JD
J Gastrointest Surg; 2008 Oct; 12(10):1683-90. PubMed ID: 18709425
[TBL] [Abstract][Full Text] [Related]
9. Advances in pancreatic cancer detection.
Tanase CP; Neagu M; Albulescu R; Hinescu ME
Adv Clin Chem; 2010; 51():145-80. PubMed ID: 20857621
[TBL] [Abstract][Full Text] [Related]
10. Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers.
Sun ZL; Zhu Y; Wang FQ; Chen R; Peng T; Fan ZN; Xu ZK; Miao Y
Biochim Biophys Acta; 2007 Jun; 1774(6):764-71. PubMed ID: 17507299
[TBL] [Abstract][Full Text] [Related]
11. A mouse to human search for plasma proteome changes associated with pancreatic tumor development.
Faca VM; Song KS; Wang H; Zhang Q; Krasnoselsky AL; Newcomb LF; Plentz RR; Gurumurthy S; Redston MS; Pitteri SJ; Pereira-Faca SR; Ireton RC; Katayama H; Glukhova V; Phanstiel D; Brenner DE; Anderson MA; Misek D; Scholler N; Urban ND; Barnett MJ; Edelstein C; Goodman GE; Thornquist MD; McIntosh MW; DePinho RA; Bardeesy N; Hanash SM
PLoS Med; 2008 Jun; 5(6):e123. PubMed ID: 18547137
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples.
Bloomston M; Zhou JX; Rosemurgy AS; Frankel W; Muro-Cacho CA; Yeatman TJ
Cancer Res; 2006 Mar; 66(5):2592-9. PubMed ID: 16510577
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in proteomic profiling of pancreatic ductal adenocarcinoma and the road ahead.
Kim H; Park J; Wang JI; Kim Y
Expert Rev Proteomics; 2017 Nov; 14(11):963-971. PubMed ID: 28926720
[TBL] [Abstract][Full Text] [Related]
14. Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach.
Park J; Lee E; Park KJ; Park HD; Kim JW; Woo HI; Lee KH; Lee KT; Lee JK; Park JO; Park YS; Heo JS; Choi SH; Choi DW; Jang KT; Lee SY
Oncotarget; 2017 Jun; 8(26):42761-42771. PubMed ID: 28514751
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of pancreatic cancer using serum proteomic profiling.
Bhattacharyya S; Siegel ER; Petersen GM; Chari ST; Suva LJ; Haun RS
Neoplasia; 2004; 6(5):674-86. PubMed ID: 15548376
[TBL] [Abstract][Full Text] [Related]
16. Analytically validated protein biomarkers of chronic pancreatitis and pancreatic cancer for potential clinical diagnosis with mass spectrometry.
Chou CY; Chang CT; Chen CJ
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8580. PubMed ID: 31502717
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling of human plasma for cancer biomarker discovery.
Huang Z; Ma L; Huang C; Li Q; Nice EC
Proteomics; 2017 Mar; 17(6):. PubMed ID: 27550791
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis.
Nie S; Lo A; Wu J; Zhu J; Tan Z; Simeone DM; Anderson MA; Shedden KA; Ruffin MT; Lubman DM
J Proteome Res; 2014 Apr; 13(4):1873-84. PubMed ID: 24571389
[TBL] [Abstract][Full Text] [Related]
19. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
[TBL] [Abstract][Full Text] [Related]
20. Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis.
Guo J; Wang W; Liao P; Lou W; Ji Y; Zhang C; Wu J; Zhang S
Cancer Sci; 2009 Dec; 100(12):2292-301. PubMed ID: 19775290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
